Meiji Seika Pharma Overview

  • Year Founded
  • 1916

Year Founded

  • Status
  • Private

  • Employees
  • 5,575

Employees

  • Investments
  • 13

Meiji Seika Pharma General Information

Description

Manufacturer of medicines intended for the treatment of infectious diseases. The company's portfolio includes antibiotics and vaccines for the treatment and prevention of infectious diseases, antidepressants for depression and schizophrenia, immunoinflammatory drugs and generic drugs along with contract pharmaceutical manufacturing capabilities.

Contact Information

Website
www.meiji-seika-pharma.co.jp
Formerly Known As
Meiji Seika Kaisha
Ownership Status
Privately Held (no backing)
Financing Status
Corporation
Corporate Office
  • 2-4-16 Kyobashi
  • Chuo-ku
  • Tokyo, 104-8002
  • Japan
+81
Primary Industry
Pharmaceuticals
Other Industries
Drug Discovery
Vertical(s)
LOHAS & Wellness, Manufacturing
Corporate Office
  • 2-4-16 Kyobashi
  • Chuo-ku
  • Tokyo, 104-8002
  • Japan
+81

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Meiji Seika Pharma Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Manufacturer of medicines intended for the treatment of infectious diseases. The company's portfolio includes antibiotic
Pharmaceuticals
Tokyo, Japan
5,575 As of 2024

Vienna, Austria
 

Stockholm, Sweden
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Meiji Seika Pharma Competitors (20)

One of Meiji Seika Pharma’s 20 competitors is Pfizer (Vienna), a Corporation company based in Vienna, Austria.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfizer (Vienna) Corporation Vienna, Austria
Gesynta Pharma Venture Capital-Backed Stockholm, Sweden
Genentech Formerly VC-backed South San Francisco, CA
Merck & Co. Corporation Rahway, NJ
Pfizer Pakistan Corporation Karachi, Pakistan
You’re viewing 5 of 20 competitors. Get the full list »

Meiji Seika Pharma Patents

  • 1,181

    Total Documents Applications and Grants

  • Total Patents Families

  • 578

    Granted

  • 94

    Pending

  • Expiring in next 12 mo

Meiji Seika Pharma Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026009973-A1 Composition comprising anti-mutant calr antibody and method for producing antibody Pending 05-Jul-2024
WO-2025244056-A1 Design method for light source, and light irradiation device Pending 22-May-2024
WO-2025243724-A1 Neuroprotective agent Pending 20-May-2024
AU-2025259752-A1 Bispecific antibody effective for patients with malignant tumors other than t-cell tumors Pending 17-Apr-2024
WO-2025220690-A1 Bispecific antibody effective for patients with malignant tumors other than t-cell tumors Pending 17-Apr-2024
To view Meiji Seika Pharma’s complete patent history, request access »

Meiji Seika Pharma Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Ready to get started?

Request a free trial

Meiji Seika Pharma Exits (2)

Meiji Seika Pharma’s most recent exit was on 04-Aug-2016 from Curadim Pharma. The exit was categorized as with 7 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
Curadim Pharma 04-Aug-2016 Completed
  • 7 buyers
Stgen Bio 01-Jan-2015 Joint Venture Completed
  • 2 buyers
To view Meiji Seika Pharma’s complete exits history, request access »

Meiji Seika Pharma Affiliates

Subsidiaries (4)

Name Industry Location Year Founded
Joint Venture (Kadmon Holdings / Meiji Seika Pharma Co.) Japan 2019
Meiji Seika Europe Amsterdam, Netherlands 1990
Medreich Bengaluru, India 1976
Ohkura Pharmaceutical Co. Kyoto, Japan 1955

Meiji Seika Pharma FAQs

  • When was Meiji Seika Pharma founded?

    Meiji Seika Pharma was founded in 1916.

  • Where is Meiji Seika Pharma headquartered?

    Meiji Seika Pharma is headquartered in Tokyo, Japan.

  • What is the size of Meiji Seika Pharma?

    Meiji Seika Pharma has 5,575 total employees.

  • What industry is Meiji Seika Pharma in?

    Meiji Seika Pharma’s primary industry is Pharmaceuticals.

  • Is Meiji Seika Pharma a private or public company?

    Meiji Seika Pharma is a Private company.

  • What is Meiji Seika Pharma’s current revenue?

    The current revenue for Meiji Seika Pharma is .

  • Who are Meiji Seika Pharma’s competitors?

    Pfizer (Vienna), Gesynta Pharma, Genentech, Merck & Co., and Pfizer Pakistan are some of the 20 competitors of Meiji Seika Pharma.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process